Evidence map›Paper›PMID 33569061›Full record

ArticleFrontiers in immunology2020

The Human Leukocyte Antigen-DPB1 Degree of Compatibility Is Determined by Its Expression Level and Mismatch Permissiveness: A German Multicenter Analysis.

Daphne Mytilineos, Chrysanthi Tsamadou, Christine Neuchel, Uwe Platzbecker, Donald Bunjes, Natalie Schub, Eva Wagner-Drouet, Gerald Wulf, Nicolaus Kröger, Niels Murawski and 14 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. HLA Linked Regional Differences in Donor Selection: A 9-Year Study of the Swiss Registry.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2023
    Article
  3. Article
  4. Article
  5. Impact of the HLA Immunopeptidome on Survival of Leukemia Patients After Unrelated Donor Transplantation.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 17 institutions in 1 country.

Daphne MytilineosInstitute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service, Baden Wuerttemberg-Hessen, and University Hospital Ulm, Ulm, Germany.
Chrysanthi TsamadouInstitute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service, Baden Wuerttemberg-Hessen, and University Hospital Ulm, Ulm, Germany.
Christine NeuchelInstitute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service, Baden Wuerttemberg-Hessen, and University Hospital Ulm, Ulm, Germany.
Uwe PlatzbeckerDepartment of Hematology/Oncology, University of Leipzig, Leipzig, Germany.
Donald BunjesDepartment of Internal Medicine III, University of Ulm, Ulm, Germany.
Natalie SchubDivision of Stem Cell Transplantation and Immunotherapy, 2nd Department of Medicine, University of Kiel, Kiel, Germany.
Eva Wagner-DrouetDepartment of Medicine III, Johannes Gutenberg-University Mainz, Mainz, Germany.
Gerald WulfDepartment of Hematology/Oncology, Georg-August-University Göttingen, Göttingen, Germany.
Nicolaus KrögerDepartment of Stem Cell Transplantation, University Hospital Hamburg Eppendorf, Hamburg, Germany.
Niels MurawskiDepartment Internal Medicine I, Universitätsklinikum des Saarlandes, Homburg, Germany.
Hermann EinseleDepartment of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
Kerstin Schaefer-EckartMedizinische Klinik 5, Klinikum Nürnberg, Paracelsus Medizinische Privatuniversität, Nürnberg, Germany.
Sebastian FreitagDepartment of Medicine III, Hematology/Oncology/Palliative Care, Rostock University Medical Center, Rostock, Germany.
Jochen CasperDivision of Hematology and Oncology, Oldenburg Clinic, University of Oldenburg, Oldenburg, Germany.
Martin Kaufmann2nd Department of Internal Medicine, Oncology and Hematology, Robert Bosch Hospital Stuttgart, Stuttgart, Germany.
Mareike DürholtDepartment of Hematology/Oncology and Stem Cell Transplantation, Evangelisches Krankenhaus Essen-Werden, Essen, Germany.
Bernd HertensteinDepartment of Hematology/Oncology, Klinikum Bremen-Mitte, Bremen, Germany.
Stefan KleinMedizinische Klinik III, Universitäts Medizin Mannheim, Mannheim, Germany.
Mark RinghofferMedizinische Klinik III, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany.
Carlheinz R MuellerZKRD - Zentrales Knochenmarkspender-Register für Deutschland, German National Bone Marrow Donor Registry, Ulm, Germany.
Sandra FrankDRST - German Registry for Stem Cell Transplantation, Ulm, Germany.
Hubert SchrezenmeierInstitute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service, Baden Wuerttemberg-Hessen, and University Hospital Ulm, Ulm, Germany.
Daniel FuerstInstitute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service, Baden Wuerttemberg-Hessen, and University Hospital Ulm, Ulm, Germany.
Joannis MytilineosInstitute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service, Baden Wuerttemberg-Hessen, and University Hospital Ulm, Ulm, Germany.
Universität Ulm · DEGerman National Bone Marrow Donor Registry · DEGerman Red Cross · DECarl von Ossietzky Universität Oldenburg · DEJohannes Gutenberg University Mainz · DEKiel University · DEKliniken Essen-Mitte · DEKlinikum Bremen-Mitte · DELeipzig University · DENuremberg Hospital · DERobert Bosch Hospital · DEStädtisches Klinikum Karlsruhe · DEUniversität Hamburg · DEUniversitätsklinikum des Saarlandes · DEUniversitätsklinikum Würzburg · DEUniversity of Göttingen · DEUniversity of Rostock · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

T-cell epitope matching according to the TCE3 algorithm classifies HLA-DPB1 mismatches in permissive and non-permissive. This classification has been shown to be predictive for mortality and acute GvHD (aGvHD) events in large international cohorts. We retrospectively genotyped HLA-DPB1 in 3523 patients transplanted in Germany between 2000 and 2014 and in their unrelated donors using an Illumina amplicon-NGS based assay. Aim of the study was to evaluate DP-compatibility beyond the established TCE3 algorithm by assessing the combined effect of several DP-mismatch parameters on post-transplant outcome. We implemented an extended DP-mismatch assessment model where TCE3, DP allotype expression with respect to rs9277534, mismatch vector and number of mismatches were conjointly taken into consideration. In this model, non-permissive HLA-DPB1 mismatches showed significantly increased aGvHD risk if they were accompanied by two HLA-DPB1 mismatches in GvH direction (HR: 1.46) or one mismatched highly expressed patient allotype (HR: 1.53). As previously reported, non-permissive HLA-DPB1 mismatches associated with a significantly higher risk of aGvHD and non-relapse mortality (HR 1.36 and 1.21, respectively), which in turn translated into worse GvHD and relapse free survival (HR 1.13). Effects on GvL and GvHD appeared strongest in GvH-directed non-permissive mismatches. Our study results support the consideration of additional HLA-DPB1 mismatch parameters along with the established TCE3 matching algorithm for refinement of future donor selection. In particular, our findings suggest that DP non-permissiveness associated with two HLA-DPB1 mismatches or at least on highly expressed mismatched patient allotype should be avoided.

Indexed as

Bone Marrow TransplantationHistocompatibilityModels, ImmunologicalPeripheral Blood Stem Cell Transplantation3' Untranslated RegionsAdolescentAdultAgedAllelesAllograftsChildChild, PreschoolEpitopes, T-LymphocyteFemaleGermanyGraft vs Host Disease3' Untranslated RegionsEpitopes, T-LymphocyteHLA-DPB1 antigenHLA-DP beta-Chainsgraft-versus-host-diseaseHLA-DPB1HLA-DPB1 expressionHLA-DPB1-permissivenessstem cell transplantation

Identifiers

PMID33569061
PMCPMC7868530
OpenAlexW3126134895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.